Study on Human Mass Balance of SPH3127 Tablets

Clinical trial NCT05593562 · COMPLETED

Trial details

NCT number: NCT05593562
Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Primary Mild and Moderate Hypertension

Start date: 2022-10-16
Primary completion: 2022-10-24
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.